HSJ Intelligence
HSJ Intelligence (HSJi)
Data and Insight Platform
HSJ Intelligence is our strategic insights tool, included with HSJ Membership, offering real-time analysis from our health media experts. Our Investigations provide in-depth overviews of NHS systems, while our National Briefings highlight trends shaping the health sector's impact on NHS organisations.
With more than 20,000 data points on each organisation, leadership teams can be prepared when deciding on strategy of how to better the operation of their own NHS organisation.
Access to financial, performance, and workforce data provides you with crucial information to support your strategic decision-making. HSJ Membership includes two HSJ Intelligence subscriptions.
Searching for Information
Reduce time spent searching for information on NHS providers
Access
Access to information not available in the public domain
Improve your Understanding
Improve your understanding of healthcare trends & predictions with HSJ market briefings
Spend Tracker
Track and analyse NHS spending behaviour, and accurately map out your market with the new add-on module for HSJ Intelligence.
Searching for Information
Reduce time spent searching for information on NHS providers
Access
Access to information not available in the public domain
Improve your Understanding
Improve your understanding of healthcare trends & predictions with HSJ market briefings
Spend Tracker
Track and analyse NHS spending behaviour, and accurately map out your market with the new add-on module for HSJ Intelligence.
“The HSJ Intelligence Briefings and Investigations are really important to us. They're coming from the people who know the most about the NHS and the editorial team are providing a massive amount of insight with those reports – we use them all the time.”
Graeme Trigg, Head of Business Development, Hempsons
“I use HSJ Intelligence every day to inform the strategic advice that I give to our managers, directors and the board. It has enabled us to connect the dots and grasp opportunities in places that we would have missed before.”
Jonathan Wedgbury, CEO, Genmed